Rabies Treatment by Exposure of Patient to X-Ray

February 14, 2020 updated by: Ahmed Samir Mohammed El Behwashy, National Institute For Research On Endemic Diseases And Liver, Egypt

Effect of X-ray on Rabies Virus in Vivo

x-ray has been proven to kill Rabies virus in vitro, so the investigators can use it in treatment of rabies infected patients.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

x-ray has been proven to kill Rabies virus in vitro, so the investigators can use it in treatment of rabies infected patients.

this can be done by exposure of infected , manifested patient who didn't receive prophylaxis or delayed in receiving immunoglobulins .

also can be applied to patients who have the injury in upper body near the CNS..

it's just an idea and the investigators need help to approve its effect and the investigators believe it will really work and give a new, rapid , cheap and very effective treatment to a 100% fatal disease..

the investigator also predict good results when x ray applied to some localized infections beside its current lines of treatment..

Study Type

Interventional

Enrollment (Anticipated)

4

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient bitten by rabid animal with signs and symptoms

Exclusion Criteria:

  • bitten by non rabid animal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: rabies patient 1
not received immunoglobulins and symptomatic
exposure of whole body to x ray
Experimental: rabies patient 2
received immunoglobulins and symptomatic
exposure of whole body to x ray
Experimental: rabies patient 3
not received immunoglobulins and not yet symptomatic
exposure of whole body to x ray
Experimental: rabies patient 4
received immunoglobulins and not symptomatic
exposure of whole body to x ray

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the number of rabies infected, symptomatic patients who survived after x-ray exposure
Time Frame: 7 month
detecting effect of x-ray exposure on treating Rabies
7 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2020

Primary Completion (Anticipated)

July 1, 2020

Study Completion (Anticipated)

July 1, 2020

Study Registration Dates

First Submitted

January 13, 2020

First Submitted That Met QC Criteria

February 6, 2020

First Posted (Actual)

February 7, 2020

Study Record Updates

Last Update Posted (Actual)

February 18, 2020

Last Update Submitted That Met QC Criteria

February 14, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • X-Ray as a treatment of Rabies

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Treatment of Rabies

Clinical Trials on x ray exposure

3
Subscribe